Clinical Trial Update: Pomalidomide Treatment in Patients With Kaposi Sarcoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for pomalidomide in patients with skin Kaposi sarcoma, sponsored by the National Cancer Institute; the study is active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Pomalyst (pomalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Skin Kaposi Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING